Natural killer cells play a critical role in mediating inflammation and graft failure during antibody-mediated rejection of kidney allografts

Kidney International

Volumn 89, Issue 6, 2016, Pages 1293-1306

  Kohei, Naoki ^a,b   Tanaka, Toshiaki ^a,c   Tanabe, Kazunari ^b   Masumori, Naoya ^c   Dvorina, Nina ^a   Valujskikh, Anna ^a   Baldwin, William M ^a   Fairchild, Robert L ^a  

^a LERNER RESEARCH INSTITUTE   (United States)

^b TOKYO WOMEN'S MEDICAL UNIVERSITY   (Japan)

^c SAPPORO MEDICAL UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

antibody mediated rejection; kidney allograft; NK cells

Indexed keywords

ANTIBODY; CXCL1 CHEMOKINE; CXCL2 CHEMOKINE; DONOR SPECIFIC ANTIBODY; GRANZYME B; IMMUNOGLOBULIN G ANTIBODY; MATRILYSIN; PERFORIN; UNCLASSIFIED DRUG; VASCULAR CELL ADHESION MOLECULE 1; CCR5 PROTEIN, MOUSE; CHEMOKINE RECEPTOR CCR5;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBODY BLOOD LEVEL; ANTIBODY DETECTION; ANTIBODY MEDIATED REJECTION; ANTIBODY TITER; ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; DOWN REGULATION; GENE EXPRESSION REGULATION; GRAFT FAILURE; GRAFT RECIPIENT; GRAFT SURVIVAL; IMMUNOPATHOGENESIS; INFLAMMATION; KIDNEY ALLOGRAFT REJECTION; KIDNEY TRANSPLANTATION; LONG TERM SURVIVAL; MALE; MMP7 GENE; MOUSE; NATURAL KILLER CELL; NATURAL KILLER CELL MEDIATED CYTOTOXICITY; NONHUMAN; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; T CELL DEPLETION; UPREGULATION; VCAM 1 GENE; WILD TYPE MOUSE; ADVERSE EFFECTS; ALLOGRAFT; ALLOTRANSPLANTATION; ANIMAL; C57BL MOUSE; CD8+ T LYMPHOCYTE; DONOR; GENETICS; GRAFT REJECTION; IMMUNOLOGY; KNOCKOUT MOUSE; MAJOR HISTOCOMPATIBILITY COMPLEX; PATHOLOGY;

ALLOGRAFTS; ANIMALS; ANTIBODIES; CD8-POSITIVE T-LYMPHOCYTES; GRAFT REJECTION; GRAFT SURVIVAL; INFLAMMATION; KIDNEY TRANSPLANTATION; KILLER CELLS, NATURAL; MAJOR HISTOCOMPATIBILITY COMPLEX; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; RECEPTORS, CCR5; TISSUE DONORS; TRANSPLANT RECIPIENTS; TRANSPLANTATION, HOMOLOGOUS;

EID: 84978101505     PISSN: 00852538     EISSN: 15231755     Source Type: Journal    
DOI: 10.1016/j.kint.2016.02.030     Document Type: Article

References (40)

1. 1 Djamali, A., Kaufman, D.B., Ellis, T.M., et al. Diagnosis and management of antibody-mediated rejection: current status and novel approaches. Am J Transplant 14 (2014), 255–271.
2. 2 Einecke, G., Sis, B., Reeve, J., et al. Antibody-mediated microcirculation injury is the major cause of late kidney transplant failure. Am J Transplant 9 (2009), 2520–2531.
3. 3 Gosset, C., Lefaucheur, C., Glotz, D., New insights in antibody-mediated rejection. Curr Opin Nephrol Hypertens 23 (2014), 597–604.
4. 4 Sellares, J., de Freitas, D.G., Mengel, M., et al. Understanding the causes of kidney transplant failure: the dominant role of antibody-mediated rejection and nonadherence. Am J Transplant 12 (2012), 389–399.
5. 5 Lefaucheur, C., Loupy, A., Vernerey, D., et al. Antibody-mediated vascular rejection of kidney allografts: a population-based study. Lancet 381 (2013), 313–319.
6. 6 Halloran, P.F., Wadgymer, A., Ritchie, S., et al. The significance of the anti-class I antibody response. I. Clinical and pathologic features of anti-class I mediated rejection. Transplantation 49 (1990), 85–91.
7. 7 Trpkov, K., Campbell, P., Pazderka, F., et al. Pathologic features of acute renal allograft rejection associated with donor-specific antibody. Analysis using the Banff grading schema. Transplantation 61 (1996), 1586–1592.
8. 8 Nickeleit, V., Andreoni, K., The classification and treatment of antibody-mediated renal allograft injury: where do we stand?. Kidney Int 71 (2007), 7–11.
9. 9 Randhawa, P., T-cell-mediated rejection of the kidney in the era of donor-specific antibodies: diagnostic challenges and clinical significance. Curr Opin Organ Transplant 20 (2015), 325–332.
10. 10 Sun, Q., Liu, L.-H., Cheng, Z., et al. Treatment of early mixed cellular and humoral renal allograft rejection with tacrolimus and mycophenolate mofetil. Kidney Int 71 (2007), 24–30.
11. 11 Hidalgo, L.G., Sellares, J., Sis, B., et al. Interpreting NK cell transcripts versus T cell transcripts in renal transplant biopsies. Am J Transplant 12 (2012), 1180–1191.
12. 12 Hidalgo, L.G., Sis, B., Sellares, J., et al. NK cell transcripts and NK cells in kidney biopsies from patients with donor-specific antibodies: evidence for NK cell involvement in antibody-mediated rejection. Am J Transplant 10 (2010), 1812–1822.
13. 13 Venner, J.M., Hidalgo, L.G., Famulski, K., et al. The molecular landscape of antibody-mediated kidney transplant rejection: evidence for NK involvement through CD16a Fc receptors. Am J Transplant 15 (2015), 1336–1348.
14. -/- recipients. Am J Transplant 8 (2008), 557–566.
15. 15 Abe, T., Ishii, D., Gorbacheva, V., et al. Anti-huCD20 antibody therapy for antibody-mediated rejection of renal allografts in a mouse model. Am J Transplant 15 (2015), 1192–1204.
16. 16 Ishii, D., Rosenblum, J.M., Nozaki, T., et al. Novel CD8 T cell alloreactivities in CCR5-deficient recipients of class II MHC disparate kidney grafts. J Immunol 193 (2014), 3816–3824.
17. 17 Racusen, L.C., Colvin, R.B., Solez, K., et al. Antibody-mediated rejection criteria-an addition to the Banff '97 classification of renal allograft rejection. Am J Transplant 3 (2003), 708–714.
18. 18 Colvin, R.B., Antibody-mediated renal allograft rejection: diagnosis and pathogenesis. J Am Soc Nephrol 18 (2007), 1046–1056.
19. 19 Lefaucheur, C., Nochy, D., Hill, G.S., et al. Determinants of poor graft outcome in patients with antibody-mediated acute rejection. Am J Transplant 7 (2007), 832–841.
20. 20 Colvin, R.B., Smith, R.N., Antibody-mediated organ-allograft rejection. Nat Rev Immunol 5 (2005), 807–817.
21. 21 Hirohashi, T., Chase, C.M., Della Pelle, P., et al. A novel pathway of chronic allograft rejection mediated by NK cells and alloantibody. Am J Transplant 12 (2012), 313–321.
22. 22 El-Sawy, T., Belperio, J.A., Strieter, R.M., et al. Inhibition of polymorphonuclear leukocyte-mediated graft damage synergizes with short-term costimulatory blockade to prevent cardiac allograft rejection. Circulation 112 (2005), 320–331.
23. 23 Kreisel, D., Sugimoto, S., Zhu, J., et al. Emergency granulopoiesis promotes neutrophil-dendritic cell encounters that prevent mouse lung allograft acceptance. Blood 118 (2011), 6172–6182.
24. 24 Rohani, M.G., Parks, W.C., Matrix remodeling by MMPs during wound repair. Matrix Biol 44-46 (2015), 113–121.
25. 25 Gill, S.E., Parks, W.C., Metalloproteinases and their inhibitors: regulators of wound healing. Int J Biochem Cell Biol 40 (2008), 1334–1347.
26. 26 Schnoor, M., Endothelial actin-binding proteins and actin dynamics in leukocyte transendothelial migration. J Immunol 194 (2015), 3535–3541.
27. 27 Halloran, P.F., Chang, J., Famulski, K., et al. Disappearance of T cell-mediated rejection despite continued antibody-mediated rejection in late kidney transplant recipients. J Am Soc Nephrol 26 (2014), 1711–1720.
28. 28 Halloran, P.F., Reeve, J.P., Pereira, A.B., et al. Antibody-mediated rejection, T cell-mediated rejection, and the injury-repair response: new insights from the Genome Canada studies of kidney transplant biopsies. Kidney Int 85 (2013), 258–264.
29. 29 Sellares, J., Reeve, J., Loupy, A., et al. Molecular diagnosis of antibody-mediated rejection in human kidney transplants. Am J Transplant 13 (2013), 971–983.
30. 30 Coutelier, J.P., Enhancement of IgG production elicited in mice by treatment with anti-CD8 antibody. Eur J Immunol 21 (1991), 2617–2620.
31. + T cells. Blood 103 (2004), 2705–2709.
32. + T cells negatively regulate IL-4-dependent, IgG1-dominant posttransplant alloantibody production. J Immunol 185 (2010), 7285–7292.
33. + T cells regulate alloantibody and eliminate alloprimed B cells through perforin- and FasL-dependent mechanisms. Am J Transplant, 14, 2014 295–2304.
34. 34 Russell, P.S., Chase, C.M., Colvin, R.B., Plate, J.M.D., Kidney transplants in mice. An analysis of the immune status of mice bearing long-term, H-2 incompatible transplants. J Exp Med 147 (1978), 1449–1468.
35. 35 Bickerstaff, A.A., Wang, J.J., Pelletier, R.P., Orosz, C.G., Murine renal allografts: spontaneous acceptance is associated with regulated T cell-mediated immunity. J Immunol 167 (2001), 4821–4827.
36. + cells. Am J Pathol 178 (2011), 1635–1645.
37. 37 Zhang, Z., Schlachta, C., Duff, J., et al. Improved techniques for kidney transplantation in mice. Microsurgery 16 (1995), 103–109.
38. 38 Rong, S., Lewis, A.G., Kunter, U., et al. A knotless technique for kidney transplantation in the mouse. J Transplant, 2012, 2012, 127215.
39. 39 Hattori, Y., Bucy, R.P., Kubota, Y., et al. Antibody-mediated rejection of single class I MHC-disparate cardiac allografts. Am J Transplant 12 (2012), 2017–2028.
40. 40 Nozaki, T., Amano, H., Bickerstaff, A., et al. Antibody-mediated rejection of cardiac allografts in CCR5-deficient recipients. J Immunol 179 (2007), 5238–5245.